Business Wire

EasyMile and Kalray Strengthen Development Platform Collaboration

Share

Autonomous technology provider EasyMile and intelligent processors supplier Kalray have deepened their relationship with the signature of a Memorandum of Understanding (MoU) formalizing their relationship to develop intelligent systems.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210106005553/en/

The partnership follows their work together in the ten-partner-strong ES3CAP collaborative project, led by Kalray and announced in 2019. The ES3CAP program, with a budget of €22.2 million over 3 years, aims to build a hardware and software platform intended for manufacturers developing critical applications requiring high computing capacity in the fields of aeronautics (aviation, flying cabs, UAVs), defense and, autonomous vehicles.

EasyMile’s technology interacts with all kinds of next-generation radars, cameras, and lidar sensors to autonomize a range of vehicles. Its vehicle-agnostic software makes it the partner of choice for global Original Equipment Manufacturers (OEMs). As a fabless company, EasyMile develops autonomous vehicle solutions that tackle identified use-cases very precisely using common-core, unique technology. EasyMile’s solutions require underlying platforms providing both safety and performance.

Benoit Perrin, Managing Director of EasyMile: “Safety and performance reliability are key to embedded systems. This collaboration with Kalray, which started with the ES3CAP program, matches the high criteria we expect of our partners and we are delighted to be working with them.”

Eric Baissus, CEO of Kalray: ”EasyMile is one of the most advanced companies delivering safe solutions for autonomous vehicles. For us, this collaboration is further evidence of the value that our MPPA® intelligent processors and SuperECU® solution can bring to easily build safe autonomous systems.”

Autonomous vehicles require ECUs (“Electronic Computing Unit”) capable of running a multitude of applications in parallel with no compromise on safety. Kalray’s SuperECU®, based on Kalray MPPA® Intelligent Processor, is a patented platform capable of providing both the demanding performance required to compute functions such as artificial intelligence algorithms but also to support multi-applications with different levels of criticality on the same chip. Kalray’s MPPA® processor is one of the rare solutions on the market to ensure complete freedom from interference between these applications, which is a key attribute in building safe systems.

In addition, Kalray intelligent processors are not only capable of executing AI algorithms but can also simultaneously execute a wide set of different processing such as mathematical algorithms, signal processing and networking software stacks. This heterogenous multi-processing capability is also a critical requirement for autonomous vehicles, and is a unique capability of Coolidge™, 3rd generation of MPPA® processor available now.

ABOUT EASYMILE

EasyMile provides software and complete solutions for driverless mobility and goods transportation. EasyMile partners with manufacturers to autonomize their vehicles with award-winning technology built on safety-by-design, ready for deployment today.

Since 2014, Easymile has become known for quality delivery and real-world deployments. Its proven technology has driven autonomous vehicles in 300+ locations in more than 30 countries: The EZ10 is the most deployed autonomous shuttle in the world. For material handling, TractEasy is a tow-truck solution optimizing supply chains with cross/indoor-outdoor, 24/7 material handling at factories and industrial sites.

With several mass operations around the world EasyMile was the first to deploy fully driverless at Level 4 of autonomous driving. It was also the first autonomous vehicle solutions provider to be ISO 9001 certified. At the core of EasyMile's cutting-edge sofware is a step-by-step approach to safety proven by a zero-collision record. EasyMile's future-ready technology specializes in robotics, computer vision and vehicle dynamics powered by deep learning. Among its customers leading transport operators, city authorities, airports, business parks, manufatcurers, factories, logistics centers and universities.

Headquartered in Toulouse, France, the company employs close to 250 highly qualified employees. In addition to the two founders, Gilbert Gagnaire and Philippe Ligier, EasyMile has investors who are also technical partners: Alstom, Continental and Bpifrance. www.easymile.com

ABOUT KALRAY

Kalray (Euronext Growth Paris - FR0010722819 - ALKAL) is a fabless semiconductor company, leading provider in a new generation of processors specialized in Intelligent Data Processing from Cloud to Edge. Kalray MPPA® Intelligent Processors are able to capture and analyze on the fly massive data flows, and interact in real time with the outside world. These processors are capable of running demanding AI algorithms and simultaneously a wide set of different processing and control tasks such as intensive mathematical algorithms, signal processing, network or storage software stacks. Kalray’s Intelligent Processors can be deployed in fast-growing sectors from Cloud to Edge: modern data centers, 5G telecom networks, autonomous vehicles, healthcare equipment, industry 4.0, drones and robots… Kalray’s offering includes processors, acceleration cards and a software suite, for a broad spectrum of customers such as next generation data center equipment manufacturers and service providers, system integrators and consumer product manufacturers such as car makers. Founded in 2008 as a spin-off of CEA French lab, Kalray counts among its investors: Alliance Venture (Renault-Nissan-Mitsubishi), Safran, NXP Semiconductors, CEA and Bpifrance. Read more at: www.kalrayinc.com

Contact information

INVESTOR CONTACTS
Eric BAISSUS
contactinvestisseurs@kalrayinc.com
Tel. +33 (0)4 76 18 90 71

ACTUS finance & communication
Jérôme FABREGUETTES-LEIB
kalray@actus.fr
+ 33 1 53 67 36 78

MEDIA CONTACTS
Loic HAMON
communication@kalrayinc.com
Tel. +33 (0)4 76 18 90 71

ACTUS finance & communication
Serena BONI
sboni@actus.fr
Tel. +33 (0)4 72 18 04 92

PRESS CONTACT
Benieke TREVERTON

benieke.treverton@easymile.com
Tel. +33 (0)7 62 83 13 44

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

GPD Companies, Inc. to Acquire Distrupol22.1.2021 14:33:00 CETPress release

GPD Companies, Inc., an affiliate of One Rock Capital Partners, LLC (“One Rock”), today announced that it has entered into a definitive agreement to acquire Distrupol, a subsidiary of Univar Solutions Inc. (NYSE: UNVR) and a leading European distributor of thermoplastics to the polymer processing industry. Terms of the transaction, which is expected to close in the first half of 2021, were not disclosed. Headquartered in Surrey, England, with broad geographic reach across Europe, Distrupol has provided value-added sales and application development of thermoplastic resins for over 50 years. Through its decades-long relationships with world class supply partners, the company offers a robust array of superior performance products and solutions that meet the needs of diverse end users from leading and emerging industries, such as the consumer, medical, automotive, and electrical sectors, among others. Distrupol caters to over 1,300 customers across 13 countries with a portfolio of over 4,0

Schlumberger Announces Fourth-Quarter and Full-Year 2020 Results22.1.2021 12:50:00 CETPress release

Schlumberger Limited (NYSE: SLB) today reported results for the fourth-quarter and full-year 2020. Fourth-Quarter Results(Stated in millions, except per share amounts)Three Months EndedChangeDec. 31, 2020Sept. 30, 2020Dec. 31, 2019SequentialYear-on-yearRevenue $5,532 $5,258 $8,228 5% -33%Income (loss) before taxes - GAAP basis $471 $(54) $452 n/m 4%Net income (loss) - GAAP basis $374 $(82) $333 n/m 12%Diluted EPS (loss per share) - GAAP basis $0.27 $(0.06) $0.24 n/m 12% Adjusted EBITDA* $1,112 $1,018 $1,648 9% -33%Adjusted EBITDA margin* 20.1% 19.4% 20.0% 73 bps 6 bpsPretax segment operating income* $654 $575 $1,006 14% -35%Pretax segment operating margin* 11.8% 10.9% 12.2% 90 bps -40 bpsNet income, excluding charges & credits* $309 $228 $545 35% -43%Diluted EPS, excluding charges & credits* $0.22 $0.16 $0.39 37% -44% Revenue by Geography International $4,343 $4,210 $5,834 3% -26%North America 1,167 1,034 2,339 13% -50%Other 22 14 55 n/m n/m $5,532 $5,258 $8,228 5% -33% *These are non-

JEOL: Release of a New Cold Field Emission Cryo-Electron Microscope CRYO ARM™ 300 II (JEM-3300)22.1.2021 07:00:00 CETPress release

JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) announces the release of a new cold field emission cryo-electron microscope (cryo-EM), the CRYO ARM™ 300 II (JEM-3300), to be released in January 2021. This new cryo-EM has been developed based on the concept of "Quick and easy to operate and get high-contrast and high-resolution images". This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005316/en/ Cold Field Emission Cryo-Electron Microscope CRYO ARM(TM) 300 II (JEM-3300) (Photo: Business Wire) Development Background Recent dramatic improvement of resolution in single particle analysis (SPA) using cryo-EM has led to SPA as an essential method for structural analysis of proteins. To address this market, JEOL released the CRYO ARM™ 300 in 2017. Equipped with a cold field emission gun (Cold FEG) for enhanced resolution and a cryo-stage for loading multiple samples, the CRYO ARM™ 300 has continued to achieve best-in-class res

ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment21.1.2021 23:12:00 CETPress release

ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) approved Cabenuva, the first and only complete long-acting regimen for the treatment of HIV-1 infection in adults. Cabenuva is provided as a co-pack with two injectable medicines — ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine— dosed once monthly, as an option to replace the current antiretroviral (ARV) regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per milliliter [mL]) on a stable regimen, with no history of treatment failure, and with no known or suspected resistance to either cabotegravir or rilpivirine. Prior to initiating treatment of Cabenuva, oral dosing of cabotegravir and rilpivirine should be administered for approximately one month to assess the tolerability of each therapy.1 Lynn Baxter, Head of North America, ViiV He

Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)21.1.2021 22:30:00 CETPress release

Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review its Biologics License Application (BLA) for retifanlimab, an intravenous PD-1 inhibitor, as a potential treatment for adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal (SCAC) who have progressed on, or who are intolerant of, platinum-based chemotherapy. The BLA submission is based on data from the Phase 2 POD1UM-202 trial evaluating retifanlimab in previously treated patients with locally advanced or metastatic SCAC who have progressed on, or are intolerant of, standard platinum-based chemotherapy. The trial enrolled 94 patients, including several with well-controlled human immunodeficiency virus (HIV) infection. The study, which was recently presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, resulted in an objective response rate (ORR) of 14% for retifanlimab monotherapy as determined by inde

Wistron and Kalray Announce FURIO1200™ Storage Appliance21.1.2021 17:45:00 CETPress release

Wistron, a leader in ICT (Information and communications technology) products, and Kalray (Paris:ALKAL) (Euronext Growth Paris: ALKAL), a leading provider in new generation of processors specialized in Intelligent Data Processing from Cloud to Edge, announce the availability of FURIO1200™, a 24-Flash-Drive NVMe-oF based storage node appliance, integrating Kalray’s NVMe-oF K200™ smart storage adapter, powered by its MPPA® Coolidge™ intelligent processor, and Wistron LYMMA chassis. FURIO1200™ is a new type of hyper-fast disaggregated storage solution delivering ultra-high throughput and reliability. It is the ideal solution for Cloud Service Providers and Enterprises running applications with intensive AI and Data Analytics workloads as well as to optimize their next generation storage. Data Centers are undergoing a very important revolution due to the explosion of usages, the surge of data to be processed and the exponential growth of the number of machines to be managed to support this

NumAlim Selects Dawex and Orange Business Services for its Data and Services Exchange Platform21.1.2021 17:40:00 CETPress release

NumAlim announced an agreement with Dawex, the leader in Data Exchange technology, and Orange Business Services, a network-native digital services company, to deploy its agri-food digital exchange platform. By relying on these two leading players, NumAlim chose secure technological solutions guaranteeing the sovereignty of French food data. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005722/en/ (Photo: Dawex) As early as Q1 2021, the NumAlim data and services exchange "Hub" will offer 18,000 companies in the food industry the opportunity to valorize, acquire and enrich all types of data: production, consumption, traceability, consumer opinions and research, as well as a wide range of services based on data (trend analysis, reformulation, regulatory watch…). "NumAlim is the answer to the needs for transparency, value creation and trust expressed by the food industry, consumers, and public authorities.” says Jérôme Fr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom